Second Sight Medical taps Blake as CFO | Personnel Moves – March 27, 2018

Second Sight Medical (NSDQ:EYES) said last week it named John Blake as its new chief financial officer, succeeding Thomas Miller who has held the position since 2014. Before joining Second Sight Medical, Blake acted as finance senior VP at Tyr Pharma, and has held positions with Volcano Corp and BD Biosciences, the company said. Blake worked with Volcano during its $1.2 billion sale to Royal Philips (NYSE:PHG) in 2015, Second Sight added. “We are delighted to welcome John to the Second Sight team. John’s financial acumen, track record of results and broad life sciences industry experience will support our efforts to grow Second Sight as we build on the momentum generated by the Argus II retinal prosthesis system and as we advance the development of the Orion cortical visual prosthesis system. In addition, John’s strengths and capabilities are well-known to me since we worked together at Volcano. It will be a genuine pleasure to work with him again,” prez & CEO Will McGuire said in a prepared statement. “John’s appointment is further evidence that the leadership team at Second Sight continues to gain the depth that is critical to achieving the Company’s business objectives and building the commercial efforts for the Argus II and Orion,” chair Gregg Williams said in a prepared release. “I am delighted to join Second Sight at this exciting time in its growth, build upon the commercial success to date of the Argus II and advance the ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News acessahealth Bayer Boston Scientific collagenmatrix Dentsply Sirona innovatusimaging integralifesciences NovaBone Nuvasive Orthovita Inc. Paradigm Spine royalphilips Second Sight Smith & Nephew Trice M Source Type: news